SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients
GHDx Entry last modified on: Mar 14, 2022
Data by Data Type
SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Tamil Nadu in October-November 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Infection in Ivory Coast: A Serosurveillance Survey among Gold Mine Workers
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020<sup>1</sup>
GHDx Entry last modified on: May 12, 2022
Socioenvironmental Factors Influencing Distribution and Intensity of Soil-Transmitted Helminthiasis in the Brazilian Amazon: Challenges for the 2030 Agenda
GHDx Entry last modified on: Jan 31, 2024
Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Seroepidemiological study of SARS-CoV-2 infection in East Java, Indonesia
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
GHDx Entry last modified on: Apr 8, 2022
Social determinants of health and coronavirus disease 2019 in pregnancy
GHDx Entry last modified on: Apr 10, 2023
Symptoms of Long-COVID 1-Year after a COVID-19 outbreak among sailors on a French aircraft carrier
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of Hepatitis E virus in children and adolescents living in urban Bogotá: An explorative cross-sectional study
GHDx Entry last modified on: Oct 23, 2024
Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of anti-SARS-COV-2 antibodies in blood donors from Nuevo Leon state, Mexico, during the beginning of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Mar 14, 2022
Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg
GHDx Entry last modified on: Mar 14, 2022
Sero-Epidemiological Survey and Profile of SARS-CoV-2 Infection in Cape Verde. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves
GHDx Entry last modified on: Jan 31, 2024
Spanish registry of Covid-19 screening in asymptomatic pregnants.
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study
GHDx Entry last modified on: Mar 8, 2024
Strengthening causes of death identification through community-based verbal autopsy during the COVID-19 pandemic
GHDx Entry last modified on: Mar 22, 2024
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study
GHDx Entry last modified on: Oct 23, 2024
Sociodemographic and Health-Related Factors Influencing Drug Intake among the Elderly Population
GHDx Entry last modified on: Oct 23, 2024
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission. Preprint
GHDx Entry last modified on: Jun 17, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit
GHDx Entry last modified on: Jan 31, 2024
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
GHDx Entry last modified on: Jan 31, 2024
SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys
GHDx Entry last modified on: May 12, 2022
Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of VZV and HSV-2 Antibodies among Women of Childbearing Age Referring to Health Centres of Mashhad, Iran: The Need for Consideration of VZV Vaccination Program
GHDx Entry last modified on: May 23, 2024
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia. Preprint
GHDx Entry last modified on: Jun 17, 2021
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district of Cameroon. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
GHDx Entry last modified on: May 12, 2022
Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing
GHDx Entry last modified on: Apr 10, 2023
Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode
GHDx Entry last modified on: Mar 22, 2024
SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1)
GHDx Entry last modified on: Jun 17, 2021
Pages
Subscribe
